integrin-binding-peptide The intracellular delivery of protein and peptide therapeutics represents a critical frontier in modern medicine, aiming to overcome the inherent challenges of getting large, complex biomolecules into cells to exert their therapeutic effects....protein-basedtherapeuticsare hampered by low bioavailability associated with inefficientintracellular delivery...ProteinswithPeptide-Based Carriers. Proteins and peptides, with their high specificity and efficacy, hold immense potential for treating a wide range of diseases, from cancer to genetic disorders. However, their journey into the cell and subsequent action are often hindered by their susceptibility to degradation, immunogenicity, and difficulty in crossing cellular membranes. Effectively achieving intracellular protein delivery is paramount for unlocking the full therapeutic promise of these biomolecules.
A primary hurdle in realizing the potential of protein and peptide therapeutics is their inability to efficiently cross the cell membrane and reach their intracellular targets. Unlike small molecules, which can readily diffuse or be transported into cells, proteins and peptides are large and hydrophilic, making direct cellular uptake difficult. This necessitates sophisticated delivery strategies that can protect these fragile molecules from degradation and facilitate their passage into the cellular environment. The goal is to ensure that therapeutic proteins and peptides reach their intended intracellular sites of action, such as the cytoplasm or nucleus, to modulate cellular pathways or correct functional deficiencies.
Numerous strategies are being explored and developed to facilitate the intracellular delivery of protein and peptide therapeutics.Peptide coacervates as intracellular delivery vehicles for ... These approaches often involve encapsulating the therapeutic cargo within specialized delivery vehicles or conjugating them with molecules that can promote cellular entry.
* Nanoparticle-Based Delivery: Nanocarriers, including liposomes, polymeric nanoparticles, and protein nanoparticles, are designed to encapsulate or bind to protein and peptide therapeutics.Intracellular delivery strategies using membrane- ... These systems can protect the cargo from enzymatic degradation in the extracellular environment and can be engineered for targeted delivery to specific cell types.Intracellular delivery strategies using membrane- ... Some nanoparticles can also facilitate endosomal escape, releasing their contents directly into the cytoplasm作者：S Yu·2021·被引用次数：104—One method forprotein deliveryinto cells involves using cell-penetratingpeptides(CPPs), which can deliverproteincargos into cells through ....
* Cell-Penetrating Peptides (CPPs): CPPs are short amino acid sequences that possess the ability to translocate across cell membranes, carrying attached cargo moleculesIntracellular Delivery of Functional Proteins via Decoration .... These peptides can be directly conjugated to therapeutic proteins or peptides, acting as "shuttles" to deliver them into the cell. Various CPPs, such as those derived from viral proteins or cationic peptides, have shown efficacy in delivering a range of biomacromolecules.
* Fusion Peptides and Protein Domains: Another approach involves fusing therapeutic proteins with specific peptide sequences or protein transduction domains (PTDs) that are known to promote cellular entry. These fusion constructs can then be expressed or administered, with the PTD facilitating the intracellular delivery of the functional protein cargo.
* Viral Vectors and Nanoparticles: Certain viral nanoparticles, such as those derived from bacteriophage P22, can be engineered to carry and deliver protein or peptide therapeuticsPeptide coacervates as intracellular delivery vehicles for .... Similarly, modified viral vectors, while more commonly associated with nucleic acid delivery, can also be adapted for protein and peptide delivery.
* Peptide Coacervates: These are complex structures formed by the association of oppositely charged peptides, which can encapsulate therapeutic molecules. Peptide coacervates offer a promising avenue for the controlled release and intracellular delivery of therapeutic agentsTrimeric cell-penetrating peptides for intracellular delivery ....
* Inkjet-Based Systems: Advanced technologies like inkjet printing are being explored to create precise delivery systems that can introduce therapeutic agents, often facilitated by CPPs, directly into cells.
Despite significant advancements, several challenges remain in the field of intracellular delivery of protein and peptide therapeutics. These include ensuring efficient delivery to the target organelle, minimizing immunogenicity, achieving controlled release, and scaling up production for clinical applicationsIntracellular delivery of protein and peptide therapeutics. Furthermore, understanding the precise mechanisms of cellular uptake and intracellular trafficking for each delivery system is crucial for optimizing their efficacy and safety.
The ongoing research and development in this area are rapidly expanding the toolkit available for delivering these powerful biomolecules effectively. As these strategies mature, they promise to unlock new therapeutic avenues for a wide spectrum of diseases, making previously intractable intracellular targets accessible for treatment. The ability to precisely deliver proteins and peptides into cells is fundamental to advancing targeted therapies and personalized medicine.
Join the newsletter to receive news, updates, new products and freebies in your inbox.